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Depression is a life-threatening psychiatric disorder characterized with a long-term hypercortisolemia in 
depressed patients. Based on this clinical feature, hypercortisolemia was mimicked in experimental animals to 
understand the neuropathogy of depression and to explore new therapeutic strategies. Wolfberry, also known as 
Lycium barbarum, is a type of common fruit produced in mainland China. Accumulated evidence has shown 
that the extracts from Lycium barbarum (LBP) had a wide range of neuroprotective effects in various neurogen-
erative models. However, the antidepressant effect of LBP on depression and its mechanism has not yet been 
explored. In the present study, we investigated the effects of LBP on counteracting depression using an animal 
model injected with moderate dose (40 mg/kg) or severe dose (50 mg/kg) of corticosterone (CORT) treatments 
for 14 days. The results showed that CORT significantly increased immobility time and decreased hippocampal 
cell proliferation. LBP treatment significantly decreased the immobility time in forced swimming test, a test for 
the intensity of depressive behaviors, both in 40 and 50 mg/kg CORT stressed rats. Moreover, LBP treatment 
restored the reduced proliferation of neuroprogentior cells in the hippocampus in 40 mg/kg CORT stressed 
rats and the neuronal differentiation but not the proliferation in 50 mg/kg CORT stressed rats. After ablation 
of adult neurogenesis with Ara-c infusion, the beneficial effect of LBP treatment in reducing immobility time 
was not affected in 40 and 50 mg/kg CORT stressed rats. Golgi staining and Western blotting detection showed 
that LBP treatment restored the reduced spine density and the decreased level of PSD-95 in the hippocampus 
caused by 40 and 50 mg/kg CORT, respectively, indicating enhanced synaptic plasticity in the hippocampus. 
The data showed a novel effect of LBP on reducing depression-like behavior and its antidepressant effect may 
be mediated by enhanced synaptic plasticity, but not hippocampal neurogenesis.
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some core symptoms and brain changes in depression 
patients (33). It has been shown that chronic exposure 
to CORT was able to induce “depressive-like” behav-
iors in several anxiety/depression tests including reduced 
sucrose consumption (13), elongation of immobility in 
forced swimming test (FST) (16,40), and in tail suspen-
sion test (40). Furthermore, CORT treatment impaired 
adult neurogenesis in the dentate gyrus and the apical 
dendritic morphology of pyramidal neurons in the CA3 
INTRODUCTION
Depression is a life-threatening psychological disor-
der worldwide. A large number of clinical observations 
have shown that a long-term hypercortisolemia existed in 
the depression patients (2). Based on this clinical feature, 
repeated corticosterone (CORT, the counterpart hormone 
of cortisol) injection in rodents has been developed as a 
preclinical model of depression since this model induces 
behavioral and neurological changes that correspond to 
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(24,36) and the CA1 subfield of hippocampus (1). These 
observations indicate that the reduced neurogenesis and 
damaged morphology in pyramidal cells in the hippocam-
pus is associated with the occurrence of depression-like 
behaviors, which are equivalent to the clinical depressive 
symptoms. Conversely, numerous studies have shown 
that administration of antidepressant drugs reduced 
depression-like behaviors (10,13), restored neurogenesis 
in the dentate gyrus (30), and induced morphological 
changes in the apical dendrites and in spine density in 
pyramidal cells in adult hippocampus (10,35). Therefore, 
increased hippocampal neurogenesis and the restored 
neuronal morphology may be involved in the recovery of 
the experimental depression.
Wolfberry, also known as Lycium barbarum, has long 
been considered to be an antiaging drug in traditional 
Chinese medicine. One of its active components, poly-
saccharides in Lycium barbarum (LBP), had been shown 
to improve cognitive functions in the intact hippocampus 
(28). Furthermore, peritoneal injection of LBP signifi-
cantly reduced the score of neurological symptoms and 
stroke index assessment in a mice ischemia–reperfusion 
model (32). The results suggest that LBP might improve 
the cerebral recovery against an ischemic challenge. In 
our laboratory, we have shown that oral feeding of LBP 
exhibited neuroprotective effects on retinal ganglion cells 
in a rat model of glaucoma (7,9). Our collaborative study 
has also shown that wolfberry can protect neurons against 
acute ischemia (21). Based on the above studies, it is rea-
sonable to investigate the neuroprotective effects of wolf-
berry in depression. However, the antidepressant effect of 
LBP has not yet been reported by others so far.
Our previous findings have shown that voluntary wheel 
running exerted antidepressant effect (i.e., decreased 
depression-like behavior that associated with restored 
hippocampal neurogenesis and increased dendritic plas-
ticity) on rats treated with moderate dose (40 mg/kg) of 
CORT (38). However, it failed to elicit antidepressant 
effects on rats with severe dose (50 mg/kg). The results 
indicated that repeated injection of CORT at different 
doses lead to different depressive stages in rats. In view 
of the neuroprotective effects of wolfberry, we therefore 
tested the antidepressant effects of LBP on the performance 
in FST in depressed rats induced by 40 and 50 mg/kg 
CORT treatment and investigated the possible molecu-
lar mechanisms underlying the neuroprotective effects 
of LBP.
MATERIALS AND METHODS
Animals and Experimental Grouping
Animals. Adult male Sprague–Dawley (SD) rats weigh-
ing 230–250 g were provided by Laboratory Animal Unit, 
the University of Hong Kong. All experimental animals 
were kept in a group of three and raised on 12-h light–
dark cycle. Rats were free to obtain food and water and 
allowed to have 24-h adaptation before the beginning of 
experiments. All procedures and animal handling were 
carried out according to guidelines set by the Committee 
on the Use of Live Animals in Teaching and Research 
(CULATR), the University of Hong Kong.
Experimental Grouping. All the experimental animals 
were divided into four separate experiments (shown in 
Fig. 1):
In experiment 1 (Fig. 1a), the rats were pretreated 
with 1 mg/kg LBP in 0.01 M PBS or the equivalent vol-
ume 0.01 M PBS prior to the 14-day cotreatment with 
CORT or vehicle (sesame oil). Thus, all rats were basi-
cally divided into four groups: (i) 7-day oral feeding of 
0.01 M PBS followed by 14-day oral feeding of PBS plus 
subcutaneous injection of vehicle; (ii) 7-day oral feed-
ing of PBS followed by 14-day oral feeding of PBS plus 
subcutaneous daily injection of CORT; (iii) 7-day oral 
feeding of LBP followed by 14-day oral feeding of LBP 
plus subcutaneous injection of vehicle; and (iv) 7-day 
oral feeding of LBP followed by 14-day oral feeding of 
LBP plus subcutaneous injection of CORT. According to 
the doses of CORT injection, all rats were injected with 
either 40 mg/kg CORT in part A or 50 mg/kg CORT in 
part B. All animals were subjected to forced swimming 
test individually 24 h after the last injection of CORT. 
One day after the end of FST, all animals were killed and 
the brains were dissected out for immunostaining.
In experiment 2, the grouping was the same as in 
experiment 1. Rats were allowed to survive for 7 days 
after the last injection of bromodeoxyuridine (BrdU) and 
euthanatized on day 28 (Fig. 1b).
In experiment 3, the grouping was the same as in exper-
iment 1. However, rats received no BrdU injection and 
were euthanatized right after the last injection of CORT. 
Fresh brains were quickly removed. One hemisphere of 
each brain was used for Golgi staining; the other hemi-
sphere was used for Western blot analysis (Fig. 1c).
In experiment 4, 42 adult male SD rats (weighed 
230 ± 20 g) were used and randomly grouped as shown 
in Figure 1d: (i) animals received saline infusion, 21-day 
oral feeding with 0.01 M PBS, and 14-day subcutane-
ous injection of sesame oil (n = 6); (ii) animals received 
saline infusion, 21-day oral feeding with 0.01 MPBS, 
and 14-day subcutaneous injection of 40 mg/kg CORT 
(n = 6); (iii) animals received saline infusion, 21-day oral 
feeding with 1 mg/kg LBP, and 14-day subcutaneous 
injection of 40 mg/kg CORT (n = 6); (iv) animals received 
cytosine-b-d-arabinofuranoside (Ara-c) infusion, 21-day 
oral feeding with 1 mg/kg LBP, and 14-day subcutaneous 
injection of 40 mg/kg CORT (n = 6); (v) animals received 
saline infusion, 21-day oral feeding of 0.01 M PBS, and 
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Figure 1. A schematic illumination of the experimental design. FST, forced swimming test; Ara-c, cytosine-b-d-arabinofuranoside; 
LBP, Lycium barbarum; CORT, corticosterone; PBS, phosphate buffered saline.
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14-day subcutaneous injection of 50 mg/kg CORT (n = 6); 
(vi) animals received saline infusion, 21-day oral feed-
ing with 1 mg/kg LBP, and 14-day subcutaneous injection 
of 50 mg/kg CORT (n = 6); (vii) animals received Ara-c 
infusion, 21-day oral feeding with 1 mg/kg LBP, and 
14-day subcutaneous injection of 50 mg/kg CORT (n = 6). 
Twenty-four hours after the last injection of CORT or ses-
ame oil, all animals were subjected to FST.
Preparation of Corticosterone and Water Extracts  
of Polysaccharides From LBP
Corticosterone (Sigma-Aldrich, St. Louis, MO, USA) 
was suspended in sesame oil as previously described 
(20,38) and then subcutaneously injected into the neck 
region of each animal at a dose of 40 or 50 mg/kg daily. A 
quick and mild massage was done on the injection site to 
prevent the leakage of CORT following every injection.
The fruit of LBP was collected from NingXia Huizu 
Autonomous Region, the People’s Republic of China. 
The water extracts of LBP were prepared from the dried 
fruit of LBP as previously described (39). Briefly, the 
dried fruit of LBP was grounded into small pieces with 
a grinder and then extracted twice with distilled hot 
water for 3 h. The combined extracts were concentrated 
and deproteinated. The resulting aqueous fractions were 
extensively dialyzed against running distilled water for 
2 days. The retentate was concentrated to 400 ml under 
reduced pressure and precipitated by addition of three 
volumes of 95% ethanol. After centrifugation and wash-
ing with acetone, the resulting precipitate was vacuum-
dried at 40°C to yield a final brown powder product. 
Generally, 1.7 g powder extracts could be achieved from 
every 100 g dried fruit. The polysaccharide concentration 
of the LBP extract was found to be 72% (39). The ready 
to use powder extracts was then dissolved in 0.01 M PBS. 
All animals were orally fed with LBP at 1 mg/kg dose 
daily or the same volume of 0.01 M PBS, starting 7 days 
prior to subcutaneous injection of CORT.
FST
Forced swimming test is a general behavior test to 
detect the “learned helplessness” in rodents, initially 
introduced by Porsolt and coworkers (29). Briefly, this 
test consists of two sessions with 24-h interval. On 
the first day, every subject was placed into a transpar-
ent plastic cylinder (height: 60 cm; diameter: 25 cm) 
half filled with warm tap water (25°C) for 15 min as a 
pretest session. Twenty-four hours later, subjects were 
placed into the cylinder again for 5 min. This part was 
the test session. All the activities in the test session were 
recorded by a video camera and scored in a blinded 
manner by a trained observer. Three types of behaviors 
are defined as follows:
Struggling was defined as upward directed move-
ments of the body, with the forepaws quickly scratching 
the inner wall of the cylinder; swimming behavior was 
defined as movement (usually horizontal) throughout the 
swim chamber which includes crossing across quadrants 
of the cylinder; and immobility, also known as floating 
behavior, was counted as no additional activity to be 
observed except the necessary movements to keep the 
nose above the water.
5-Bromodeoxyuridine (BrdU) Injection  
and Tissue Preparation
BrdU powder (Sigma) was dissolved in 0.9% saline 
solution and injected peritoneally to each animal on days 
19, 20, and 21 (Fig. 1) at 50 mg/kg in 12-h interval. For 
the analysis of proliferation, 1 day after the last BrdU 
injection, one half of the animals was anesthetized with 
an overdose of sodium pentobarbital and perfused tran-
scardially with 0.9% saline, followed by 4% paraformal-
dehyde. For the analysis of neuronal differentiation, the 
other half of the animals was anesthetized and perfused in 
the same way (Fig. 1). All brains were collected and post-
fixed in 4% paraformaldehyde at 4°C overnight. Then all 
brains were immersed in 30% sucrose solution and 48 h 
later were serially cryosectioned at 40 µm coronally from 
bregma -3.30 to -4.52 mm (27). Twelve serial slices 
were collected in a 24-well plate and stored in cryopro-
tectant at -20°C.
BrdU Immunohistochemistry and Quantification
Serial slices in one well were used and mounted onto 
slides precoated with 0.25% gelatin. Sections were then 
placed in 0.01 M citric acid (pH 6.0) for 30 min at 95°C, 
followed by 0.01 M PBS rinse. All sections were then 
denatured in 2 M HCl for 30 min at 37°C, followed by 
boric acid buffer (pH 8.5) for 15 min at room tempera-
ture. After three time rinses of 0.01 M PBS, sections 
were incubated for 30 min with 3% hydrogen peroxide. 
After blocking with 10% normal goat serum for 1 h, 
sections were incubated with mouse anti-BrdU antibody 
(1:1,000, Roche Molecular Biochemicals, Essex, UK) 
overnight at room temperature. Following three time 
rinses of 0.01 M PBS, sections were incubated with 
biotinylated goat anti-mouse antibody (1:200 Vector 
Laboratories, Inc., Burlingame, CA) for 1 h at room tem-
perature. Then sections were incubated with an avidin– 
biotin complex (Vector Laboratories) for 30 min. 
Following three time rinses of 0.01 M PBS, all sections 
were incubated with diaminobenzidine. The diamin-
obenzidine was removed when appropriate color was 
developed. At last, all sections were counterstained with 
eosin. Being dehydrated in gradient alcohol and cleared 
in toluene solution.
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The number of BrdU-positive cells, located in the 
dorsal hippocampus (six sections per animal), was 
calculated by using the software StereoInvestigator 
(MicroBrightField, Williston, VT) and the 40´ objective 
lens. Briefly, in every section, the contour of the granular 
cell layer (GCL) and subgranular zone (SGZ; a two cell-
wide area just under GCL) was first outlined under the 
10´ objective lens. After switching to 40´ lens, the soft-
ware randomly picked out about 30 counting frames in the 
contour and BrdU-positive cells in each counting frame 
were calculated by a skilled observer. After counting all 
the six sections in one animal, the total cell number in this 
animal was estimated by the software. The whole process 
of calculation was conducted in a blinded manner.
Fluorescence Staining and Quantification  
of Neurogenesis
For phenotype analysis, 30 BrdU-positive cells per 
animal were randomly selected and then were checked 
for the colabeling of BrdU (1:1,000 Abcam) and dou-
blecortin (DCX, 1:100, Abcam, USA). Ratios of colabel-
ing were counted as the following formula:
Ratio of colabeling = number of BrdU+DCX+ in 30 
BrdU+ cells / 30 ´  100%.
The whole process of analysis was conducted in a 
blinded manner.
Protein Extraction and Western Blotting Analysis
Hippocampal tissue in experiment 2 was rapidly 
dissected out after an appropriate treatment period. 
Samples were snap-frozen in liquid nitrogen and then 
stored at -80°C until use. Samples were homogenized 
in 500 µl lysis buffer containing phosphatase inhibitor 
(Calbiochem, Cat. No. 524628) and protease inhibitor 
cocktail (Sigma, Cat. No. P8340). Homogenate were kept 
on ice for 30 min followed by centrifuge at 14,000 rpm, 
4°C for 30 min. The supernatant was then harvested and 
protein concentration was determined using the protein 
assay kit (Bio-Rad, Cat. No. 5000116).
To examine the level of synaptophysin (SYP) and post-
synaptic density protein-95 (PSD-95), equal amounts of 
protein were subjected to sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis (20 µg protein/lane) 
using 10% polyacrylamide gels. Afterwards, the proteins 
were transferred onto a polyvinylidene difluoride (PVDF) 
membrane, followed by blocking with 5% nonfat dry milk 
in Tris-buffered saline and Tween 20 (TBST). The mem-
brane was then incubated with mouse anti-SYP (1:5,000) 
(Sigma) and rabbit anti-PSD-95 (1:2,500) (Cell Signaling 
Technology, CST) for 2 h at room temperature, followed 
by the incubation of horseradish peroxidase-conjugated 
secondary antibodies (1:2,000) for 1 h at room tempera-
ture. Bands were visualized on a Biomax X-ray film using 
the ECL detection kit. The membranes were then stripped 
with the Re-Blot Western blot recycling kit and reprobed 
with monoclonal anti-b-actin antibody (1:15,000) as inter-
nal control.
Golgi Staining and Analysis
Golgi staining was performed with FD Rapid Golgi 
Staining Kit (FD NeuroTechnologies, USA, Cat. No. 
PK401) according to the manufacturer’s instructions. In 
brief, freshly dissected brain was left in impregnation 
solutions A and B containing potassium dichromate and 
chromate for 2 weeks at room temperature. After being 
replaced with solution C for 48 h at 4°C, the brain tissue 
was sectioned into 150 µm and fixed to gelatin-coated 
slides. Solutions D and E and distilled water (1:1:2 ratio) 
were used for staining the pyramidal neurons for 10 min, 
followed by dehydration in 50%, 75%, 95% ethanol and 
absolute ethanol and finally cleared in toluene and cov-
ered by coverslips in permount. Neurons were analyzed 
by Neurolucida (MicroBrightField) and selected accord-
ing to methods described by Woolley et al. (36),
 relative isolation from neighboring impregnated 1. 
neurons to avoid interference with analysis;
 cell bodies located in the middle part of the section 2. 
thickness to minimize the loss of branch segments;
 consistent and dark impregnation along the entire 3. 
extent of all of the dendrites;
 located in the appropriate subregion of the dorsal 4. 
hippocampus.
Three CA3 pyramidal cells in each animal were 
selected and drawn at the 200´ lens. Spine density was 
estimated by randomly selecting high-magnification trac-
ing of a 15-µm long terminal segment of the basal/apical 
dendritic branch. Three to five tertiary apical dendrites 
and basal dendrites that had at least one branch point 
were selected for measurement. Visible spines along the 
branch segment were counted, and data were expressed 
as spine number/10 µm.
Intracerebroventricular Infusion of Ara-c
All animals were infused as previously described (18). 
Briefly, each animal was anesthetized and fixed in a ste-
reotaxic stage. The top of the skull was exposed and a 
hole over the right lateral ventricle (2.0 mm posterior and 
1.5 mm lateral to bregma) was drilled. An osmotic pump 
(Alzet, model 2004, Palo Alto, CA, USA; flow rate at 
0.25 µl/h) containing Ara-c (4%, Sigma) in 0.9% saline 
or 0.9% saline alone was implanted into the subcutaneous 
space of the neck of the rat with a 4.0-mm metal cannula 
crossing through the hole. The osmotic pump was pre-
assembled according to the instruction. After the suturing 
the skin, every animal was put back to a warm cage and 
allowed for a 48-h recovery.
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Statistic Analysis
All data were presented as mean ± standard error of 
mean (SEM) and were analyzed using two-way ANOVA, 
with LBP treatment in the CORT-treated and nontreated 
groups as between-subjects factors. Following ANOVA 
analyses, Dunnett’s post hoc tests were used via the 
Statistical Analysis System. Values of p < 0.05 were 
regarded as statistically significant.
RESULTS
Effects of LBP on Depression-Like Behavior in the FST
In experiment 1, three types of typical behaviors were 
recorded in FST. In part A of experiment 1 (Fig. 2a), daily 
injection of 40 mg/kg CORT for 14 days was admin-
istered. In the immobile activity, a two-way ANOVA 
indicated a significant CORT effect [F(1, 14) = 14.45, 
p = 0.002] and a significant LBP effect [F(1, 14) = 23.51, 
p < 0.001] and CORT ´  LBP interaction [F(1, 14) = 17.24, 
p = 0.001]. After the injection of 40 mg/kg CORT for 
14 days, a significantly longer immobility was observed 
when compared to the PBS group (p < 0.001). Treatment 
with 1 mg/kg LBP for 21 days alone showed no effects 
on immobile time when compared to the PBS group 
(p > 0.05). The LBP + 40C group showed significantly 
shortened immobility time in the LBP + 40C group when 
compared to the CORT group (p < 0.001) (Fig. 2a). In a 
struggling activity, a two-way ANOVA indicated no CORT 
effect [F(1, 14) = 1.308, p > 0.05], no LBP effect [F(1, 
14) = 1.308, p > 0.05], and no CORT ´  LBP interaction 
[F(1, 14) = 0.43, p > 0.05] (Fig. 2b). In a swimming activ-
ity, a two-way ANOVA indicated a significant CORT 
effect [F(1, 14) = 10.48, p = 0.006] and no significant LBP 
effect [F(1, 14) = 3.45, p > 0.05] and CORT ´  LBP interac-
tion [F(1, 14) = 9.33, p = 0.009]. After injection of 40 mg/
kg CORT for 14 days, a significantly shorter swimming 
activity was observed when compared to the PBS group 
(p < 0.001) (Fig. 2c). Treatment of 1 mg/kg LBP for 21 
days alone showed no effects on the swimming activity 
when compared to the PBS group (p > 0.05) (Fig. 2c). 
The combined LBP + 40C showed a significantly longer 
swimming time when compared to the PBS + 40C group 
(p = 0.005) (Fig. 2c).
In the set B of experiment 1, 50 mg/kg CORT was 
administered. In the immobile activity, two-way ANOVA 
analysis indicated a significant CORT effect [F(1, 
15) = 26.30, p < 0.001] and a significant LBP effect [F(1, 
15) = 16.84, p = 0.001] and CORT ´  LBP interaction [F(1, 
15) = 15.46, p = 0.001]. After injection of 50 mg/kg CORT 
for 14 days, a significantly longer immobility time was 
observed when compared to the PBS group (p < 0.001) 
(Fig. 2d). Treatment of 1 mg/kg LBP for 21 days alone 
showed no effects on the immobile activity when compared 
to the PBS group (p = 0.902). The combined treatment of 
1 mg/kg LBP for 21 days plus injection of 40 mg/kg CORT 
for 14 days showed a significantly shorter immobility time 
when compared to the CORT group (p < 0.001) (Fig. 2d). 
In struggling activity, two-way ANOVA analysis indicated 
no CORT effect [F(1, 13) = 0.839, p > 0.05], no LBP effect 
[F(1, 13) = 0.084, p > 0.05], and no CORT ´  LBP interaction 
Figure 2. Effects of CORT injection and 1 mg/kg LBP treatment on the FST performance. Quantitative analysis of three types of 
activities including immobility (a), struggling (b), and swimming (c) of the FST performance in different groups receiving 40 mg/kg 
CORT injection and 1 mg/kg LBP feeding. Quantitative analysis of immobility (d), struggling (e), and swimming (f) in the FST per-
formance in different groups received 50 mg/kg CORT injection and 1 mg/kg LBP feeding. **p < 0.01 compared to the PBS group; 
##p < 0.01 compared to the PBS + 40C group or the PBS + 50C group. FST, forced swimming test; LBP, Lycium barbarum; CORT, 
corticosterone; PBS, phosphate buffer; 40C, 40 mg/kg corticosterone; 50C, 50 mg/kg corticosterone.
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[F(1, 13) = 0.412, p > 0.05] (Fig. 2e). In a swimming activ-
ity, two-way ANOVA indicated a significant CORT effect 
[F(1, 13) = 9.445, p = 0.009] and no significant LBP effect 
[F(1, 13) = 1.621, p > 0.05] and CORT ´  LBP interaction 
[F(1, 13) = 0.619, p = 0.009]. After injection of 50 mg/kg 
CORT for 14 days, a significantly shorter swimming 
activity was observed when compared to the PBS group 
(p = 0.015). Treatment of 1 mg/kg LBP for 21 days alone 
showed no effects on the swimming activity when com-
pared to the PBS group (p > 0.05). Combined treatment 
of 1 mg/kg LBP for 21 days plus injection of 50 mg/kg 
CORT for 14 days failed to shorten swimming time when 
compared to the CORT group (p > 0.05) (Fig. 2f). All the 
above data indicated that LBP treatment was able to reduce 
“depressive-like” behaviors in the FST caused by 40 and 
50 mg/kg CORT treatment, respectively.
Effects of LBP on the Hippocampal Neurogenesis
LBP Restored Hippocampal Cell Proliferation in 
40 mg/kg CORT-Treated Rats, but Failed to Do so in 
50 mg/kg CORT-Treated Rats. Figure 3a showed a coro-
nary brain section containing the dorsal dentate gyrus, 
and Figure 3b showed that the BrdU-positive cells located 
beneath the granular cell layer. Compared to the number 
of BrdU-positive cells (5,715 ± 850) in the PBS group, 
the number of BrdU-positive cells in rats with 40 mg/
kg CORT treatment in the PBS + 40C group significantly 
reduced to 48% (2,746 ± 801, p = 0.02). The number of 
BrdU-positive cells in the LBP group showed no signifi-
cant change, indicating that LBP treatment alone did not 
elicit any effect on the proliferation of neural progenitor 
cells in the hippocampus. Compared to the cell number in 
the PBS + 40C group, the number of BrdU-positive cells 
significantly increased (5,393 ± 687, p = 0.033) in the 
LBP + 40C group, indicating treatment with LBP signifi-
cantly restored the BrdU-positive cells in rats treated with 
40 mg/kg CORT (Fig. 3c).
The results of BrdU staining in part B of experiment 
1 (50 mg/kg CORT injection) was shown in Figure 3d–f. 
Compared to the number of BrdU-positive cells in the 
PBS group (6,454 ± 672), the cell number in the PBS + 50C 
group significantly reduced to 2,867 ± 463 (p < 0.001). 
Compared to the PBS + 50C group, there was no differ-
ence in the number of BrdU-positive cells (3,604 ± 642, 
p > 0.05) in the LBP + 50C group, suggesting that LBP 
treatment was unable to restore the proliferation of neural 
progenitor cells suppressed by 50 mg/kg CORT injection 
(Fig. 3e, f).
Effects of LBP on the Differentiation of Neural 
Progenitor Cells in the Hippocampus in the 40 mg/
kg CORT-Injected and 50 mg/kg CORT-Injected Rats. 
Colabeling of BrdU and DCX was used to estimate the 
neuronal differentiation of newly born cells. In 40 mg/kg 
CORT-treated rats, the ratio of DCX+/BrdU+ cells to 
BrdU+ cells in the PBS + 40C group did not show any 
difference when compared to that in the PBS group 
(p > 0.05). Similarly, the ratio of DCX+/BrdU+ cells 
to BrdU+ cells in both the LBP group and LBP + 40C 
group did not demonstrate any difference when com-
pared to that in the PBS group (p > 0.05) (Fig. 4b). 
However, the ratio of DCX+/BrdU+ cells to BrdU+ cells 
in the PBS + 50C group was significantly lower than 
that in the PBS group (p = 0.005). The ratio of DCX+/
BrdU+ cells to BrdU+ cells in the LBP + 50C group was 
significantly higher than that in the PBS + 50C group 
(p = 0.028) and comparable to that in the PBS group 
(p > 0.05) (Fig. 4c).
Effects of LBP on Dendritic Morphology of CA3 
Pyramidal Cells in the CORT-Treated Rats (Fig. 5)
No Effect of LBP and 40 mg/kg CORT on Soma Size 
and Dendritic Length. Figure 5a illustrated a qualified 
Gogli-impregnated CA3 pyramydal cell (left) and the 
outline of the neurites by Neurolucida software (right). 
After a 14-day injection of 40 mg/kg CORT, quantitative 
analysis of CA3 pyramidal cells did not show any signifi-
cant decrease neither in either cell body area (Fig. 5b) or 
in dendritic length of basal dendrites (Fig. 5d) and apical 
dendrites (Fig. 5d). The data indicated that 14-day injec-
tion of 40 mg/kg CORT did not decrease the pyramidal 
cell body and did not reduce dendrites in pyramidal cells 
of the CA3 region.
Alteration in Apical Spine Density by 40 mg/kg CORT 
and LBP Treatment. The spine density in the basal dendrites 
was not affected by 40 mg/kg CORT or by LBP (Fig. 5f) 
(p > 0.05). However, comparing to spine density in apical 
dendrites in the PBS group, spine density in apical dendrites 
was significantly reduced in the PBS + 40C group (p < 0.05). 
In comparison to the PBS + 40C group, spine density was 
significantly increased (p < 0.05) in the LBP + 40C group. 
The data indicated that LBP restored the reduced spine den-
sity caused by 40 mg/kg CORT (Fig. 5f). In addition, LBP 
alone did not affect spine density in the basal and apical den-
drites of pyramidal cells (Fig. 5f) (p > 0.05).
Effects of LBP and 50 mg/kg CORT on Soma Size and 
Dendritic Length in CA3 Pyramidal Cells. After 14-day 
injection of 50 mg/kg CORT, quantitative analysis of cell 
body area of CA3 pyramidal cells in the PBS + 50C group 
showed a decreasing trend (Fig. 5c) (p = 0.071) when com-
pared to the cell body area in the PBS group. The cell body 
area in the LBP + 50C group was restored to the baseline 
and showed no difference in the cell body area when com-
pared with the PBS group. No significant change was 
detected in the length of basal dendrites (Fig. 5e) and api-
cal dendrites (Fig. 5e). These data indicated that a 14-day 
injection of 50 mg/kg CORT, somehow, induced an atro-
phy in the pyramidal cell body, while LBP treatment was 
able to reverse the atrophy of the pyramidal cell body.
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Alteration in the Apical Spine Density by 50 mg/kg 
CORT and LBP Treatment. Spine density in basal dendrites 
was unchanged either by 50 mg/kg CORT or LBP treatment 
(Fig. 5g) (p > 0.05). However, comparing to spine density 
in apical dendrites in the PBS group, spine density in apical 
dendrites in the PBS + 50C group was significantly reduced 
(p < 0.05). Comparing to spine density in the PBS + 50C 
group, spine density significantly increased (p < 0.05) in 
the LBP + 50C group. These data suggest that LBP treat-
ment was able to restore the decrease spine density in 
apical dendrites caused by 50 mg/kg CORT injection (Fig. 
5g). Also, in this part of the experiment, LBP alone did not 
affect the spine density in the basal and apical dendrites of 
the pyramidal cells (Fig. 5g).
Effects of LBP on Hippocampal Expression Level of SYP 
and PSD-95 (Fig. 6)
LBP Increased the Expression of PSD-95 in 40 mg/kg 
CORT-Treated Rats. Figure 6a showed the results of the 
expression level of SYP and PSD-95, two dominant synaptic 
Figure 3. Immunohistochemical staining and quantitative analysis of BrdU-positive cells in dentate gyrus in groups receiving 40 and 
50 mg/kg CORT injection. (a) Nissl staining of the half coronary brain section. (b) BrdU immunohistochemistry in different groups receiving 
40 mg/kg CORT injection. Scale bar: 100 µm. (c) Quantitative analysis of BrdU-positive cell number in different groups receiving 40 mg/
kg CORT injection. (d) Nissl staining of the half coronary brain section. (e) BrdU immunohistochemistry in different groups receiving 
50 mg/kg CORT injection. Scale bar: 100 µm. (f) Quantitative analysis of BrdU-positive cell number in different group receiving 50 mg/kg 
CORT injection. *p < 0.05 compared to the PBS group; #p < 0.05 compared to the PBS + 40C group. BrdU, bromodeoxyuridine; PBS, 
phosphate buffer; LBP, Lycium barbarum; 40C, 40 mg/kg corticosterone; 50C, 50 mg/kg corticosterone.
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proteins in experiment 3 by Western blotting. Neither 40 mg/
kg CORT nor LBP induced an obvious change in the expres-
sion of SYP in all four groups (Fig. 6c) (p > 0.05). However, 
the expression level of PSD-95 was significantly decreased 
in the PBS + 40C group when compared to the level in the 
PBS group (p = 0.003). The expression level of PSD-95 was 
increased in the LBP + 40C group when compared to the 
level in the PBS + 40C group (Fig. 6e) (p = 0.003).
LBP Also Increased the Expression of PSD-95 in 50 
mg/kg CORT-Injected Rats. Figure 6b showed the results 
of the expression level of SYP and PSD-95 in 50 mg/kg 
CORT treatment by Western blotting. Neither 50 mg/kg 
CORT nor LBP induced a change in the expression of SYP 
in all four groups (Fig. 6d) (p > 0.05). Similarly, expression 
level of PSD-95 did not show any significant decrease in 
the PBS + 50C group when compared to the level in the PBS 
group (Fig. 6f) (p > 0.05). The expression level of PSD-95 
robustly increased in the LBP + 50C group when compared 
to the level in the PBS + 50C group (Fig. 6f) (p = 0.046).
Ara-c Infusion Did Not Block the Counteractive Effect  
of LBP on CORT-Treated Rats (Fig. 7)
Ara-c Infusion Abolished the BrdU-Positive Cells in 
the Dentate Gyrus. Figure 7a showed the tract made by 
the metal cannula of the osmotic pump. The tract clearly 
showed that the 4-mm long cannula entirely penetrate the 
cortex allowing the release of Ara-c or 0.9% saline into 
the right lateral ventricle near the hippocampal fornix, a 
part that was just anterior to the dorsal hippocampus.
BrdU-positive cells were detected in the groups with saline 
infusion (Fig. 7b–d, f–g). However, no BrdU-positive cells 
were observed in the groups with Ara-c infusion (Fig. 7e, h). 
Similar to previous findings (20,38), both BrdU-positive cell 
number was greatly decreased in the Sa + PBS + 40C group 
and Sa + PBS + 50C group (Fig. 7c, e) when compared to the 
number in the Sa + PBS group (control).
Ara-c Infusion Did Not Block the Antidepressant 
Effect of LBP on 40 and 50 mg/kg CORT-Treated Rats. 
Figure 8 showed the immobile period time in different 
groups. Three-way ANOVA analysis revealed a signifi-
cant CORT effect [F(1, 21) = 5.865, p = 0.009] and a sig-
nificant CORT ´  LBP effect [F(1, 21) = 6.650, p = 0.006] 
and no CORT ´  LBP ´  Ara-c interaction [F(1, 21) = 0.664, 
p = 0.525]. These data indicated that similar to previous 
findings, compared to the immobile time in the Sa + PBS 
group, the immobile time significantly increased in both 
the Sa + PBS + 40C (p < 0.01) and the Sa + PBS + 50C 
groups (p < 0.01). However, 1 mg/kg LBP significantly 
decreased the immobile time both in the Sa + LBP + 40C 
and the Sa + LBP + 50C groups. These data indicated that 
the infusion of normal saline had no effluence on the 
beneficial effects of LBP treatment. Furthermore, in the 
Ara-c + LBP + 40C and the Ara-c + LBP + 50C groups, it 
was proved that the Ara-c infusion was unable to block the 
behavioral improvement of LBP treatment as shown in the 
FST both in 40 and 50 mg/kg CORT-treated rats.
DISCUSSION
In the present study, we investigated whether LBP exhi-
bited a counteractive effect on depression-like behavior in 
FST induced by a sophisticated stress model by repeated 
CORT injections (14,38). Also, we further determined 
whether the beneficial effects of LBP were mediated 
by hippocampal neurogenesis or were associated with 
dendritic plasticity in hippocampus. Our results showed 
that LBP reduced the depression-like behavior in FST 
both in 40 and 50 mg/kg CORT-treated rats. The effects 
of LBP were associated with recovered spine density in 
pyramidal cells as well as with the increased expression 
of PSD-95 in hippocampus. Ablation of neurogenesis by 
Ara-c infusion did not block the antidepressant effects of 
LBP treatment on reducing the depression-like behaviors 
in FST both in 40 and 50 mg/kg CORT-treated rats. The 
above data indicate that the antidepressant effects of LBP 
may not require hippocampal neurogenesis but is asso-
ciated with enhanced dendritic plasticity and increased 
expression of certain synaptic proteins.
Figure 4. Differentiation of the neural progenitor cells the den-
tate gyrus in experiment 2. (a) Double-labeling of BrdU (red) 
and doublecortin (DCX, green) cells in the dentate gyrus. Scale 
bar: 10 µm. (b) Quantitative analysis of DCX+BrdU+ cells to 
BrdU+ cells ratio in part A of experiment 2 (40 mg/kg CORT). 
(c) Quantitative analysis of DCX+BrdU+ cells to BrdU+ cells 
ratio in part B of experiment 2 (50 mg/kg CORT). *p < 0.05 
compared to PBS group; #p < 0.05 compared to the PBS + 40C 
group/the PBS + 50C group. BrdU, bromodeoxyuridine; PBS, 
phosphate buffer; LBP, Lycium barbarum; 40C, 40 mg/kg corti-
costerone; 50C, 50 mg/kg corticosterone.
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LBP Exhibits Antidepression Effects in Both 40  
and 50 mg/kg CORT-Treated Rats
Chronic exposure to high dose of CORT has been com-
monly adopted to establish stress model in experimental 
animals (4,22,36). More interestingly, the recent data in 
our laboratory have proved that 14-day injection of CORT 
using 30 mg/kg (low), 40 mg/kg (mediate), and 50 mg/kg 
(high) led to a graded increase in depression-like behav-
ior and impaired spatial learning. Furthermore, volunteer 
running reversed those behavioral deficits in rats treated 
with 30 or 40 mg/kg but not 50 mg/kg of CORT (38). 
Thus, CORT injection provides a sophisticated control on 
depression-like behavior in animals in terms of increas-
ing the immobility time. According to the above findings, 
doses at 40 and 50 mg/kg CORT were chosen to induce the 
“running-reversible” depression model and the “running-
irreversible” depression model in rats, respectively; in this 
study, LBP was employed to antagonize the depression-like 
behaviors in FST. The present findings showed that LBP 
significantly decreased the immobile time and increased 
Figure 5. Golgi staining and quantitative analysis data of pyramidal cells after LBP and CORT treatment. (a) Left: representative image 
of a selected pyramidal neuron for analysis; right: the drawing image created by Neurolucida. Scale bar: 50 µm. (b, c) Quantitative 
analysis of soma size in different groups. (d, e) Quantitative analysis of basal dendritic length and apical length in different groups. 
(f, g) Quantitative analysis of spine density on apical and basal dendrites in different groups. *p < 0.05 compared to PBS group; 
#p < 0.05 compared to the PBS + 40C/50C group. PBS, phosphate buffer; LBP, Lycium barbarum; 40C, 40 mg/kg corticosterone; 50C, 
50 mg/kg corticosterone.
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the swimming time in FST in both 40 and 50 mg/kg CORT-
treated rats. This data indicate that LBP exhibits an anti-
depressant effect in the CORT-treated rats. Neuroprotective 
effects of LBP have been extensively proved in various 
neurodegenerative models (8). Previous studies have found 
that polysaccharides in LBP are able to improve cognitive 
function in the intact hippocampus (28). Furthermore, peri-
toneal injection of LBP can significantly reduce the score 
of neurological symptoms and stroke index assessment in 
a mice model of ischemia–reperfusion (32). Therefore, 
LBP improves the cerebral recovery against an ischemic 
challenge. Our results showing the antidepressant effects 
of LBP treatment are among the first to prove that LBP 
elicits beneficial effects on psychiatric disorders and added 
the knowledge in the neuroprotection of LBP in the central 
nervous system (CNS). Furthermore, the findings showing 
that LBP reversed the behavioral deficits caused by 50 mg/
kg CORT injection indicate that LBP has a more potent 
therapeutic effect on counteracting depression-like behav-
iors than running did, since running showed no effects on 
counteracting the behavioral deficits in 50 mg/kg CORT-
treated rats (38). One possible explanation here is that this 
potent therapeutic effect of LBP may be due to 7-day pre-
treatment regimen.
Figure 6. Western blot detection of SYP and PSD-95 in the hippocampus in 40 and 50 mg/kg CORT-treated rats. (a) Positive 
bands in SYP and PSD-95 detection after 40 mg/kg CORT and LBP treatment. (b) Positive bands in SYP and PSD-95 detection. 
(c, d) Quantitative analysis of SYP expression in different groups. (e, f) Quantitative analysis of PSD-95 expression in different 
groups.*p < 0.05 compared to PBS group; #p < 0.05 compared to the PBS + 40C/50C group. PBS, phosphate buffer; LBP, Lycium barba-
rum; 40C, 40 mg/kg corticosterone; 50C, 50 mg/kg corticosterone; SYP, synaptophysin; PSD-95, postsynaptic density protein 95.
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LBP Restores the Hippocampal Neurogenesis  
in CORT-Treated Rats
The “Neurogenesis hypothesis” in depression has 
been first proposed by Gage and colleagues (17) since 
numerous studied have shown that hippocampal neuro-
genesis was greatly reduced in animal models (6,12,37). 
Reduction of neurogenesis can be recovered after 
treatment of antidepressant drugs or in the healing 
phase of depression (5). These findings indicate that 
hippocampal neurogenesis not only respond to antide-
pressant treatment but also contribute to the recovery 
of depression. By using BrdU and DCX/BrdU immuno-
histochemical staining, we detected the effects of CORT 
and LBP treatment on the process of hippocampal 
neurogenesis: cell proliferation and neuronal differen-
tiation. Our results showed that the proliferation was 
greatly impaired by 40 mg/kg CORT and 50 mg/kg 
CORT injection. In addition, 50 mg/kg CORT injection 
reduced neuronal differentiation of neuroprogenitor 
cells in the hippocampus. After cotreatment with LBP, 
the proliferation was totally restored in the 40 mg/kg 
CORT-treated rats. However, the proliferation was not 
restored in the 50 mg/kg CORT-treated rats, and neu-
ronal differentiation was recovered in 50 mg/kg CORT-
treated rats. The above data indicate that LBP is likely 
to elicit its antidepressive effects by improving hip-
pocampal neurogenesis in different aspects. As a result, 
the recovery of hippocampal neurogenesis may be a 
potential factor in mediating the antidepressant process 
of LBP treatment.
The Antidepressant Effects of LBP Treatment  
Is Not Blocked by the Ara-c Infusion
To better understand whether adult neurogenesis 
mediates the antidepressant effects of LBP, Ara-c infu-
sion was adopted to inhibiting the newly born cells 
from the pool of neural progenitor cells in the dentate 
gyrus. It was found that, after Ara-c infusion, LBP 
could retain its ability to reduce the immobile time in 
FST in both 40 and 50 mg/kg CORT-treated rats. This 
finding can be attributed to two possible explanations. 
First, other factors beyond neurogenesis are underlying 
Figure 7. Entire abolishment of BrdU-positive cells in the 
dentate gyrus by Ara-c infusion. (a) Coronary section of the 
cerebrum across the penetrate site of the metal cannula of 
the osmotic pump. Arrow, the tract made by the cannual of 
the osmotic pump; asterisk, bilateral hippocampal fornix. 
Scale bar: 200 µm. (b–h) Immunohistochemical staining of 
BrdU in dentate gyrus in different groups. Scale bar: 100 µm. 
a + PBS, saline infusion + 0.01 M PBS + sesame oil injection; 
Sa + PBS + 40C, saline infusion + 0.01 MPBS + 40 mg/kg CORT 
injection; Sa + LBP + 40C, saline infusion + 1 mg/kg LBP + 40 mg/
kg CORT injection; Ara-c + LBP + 40C, Ara-c infusion + 1 mg/kg 
LBP + 40 mg/kg CORT injection; Sa + PBS + 50C, saline infu-
sion + 0.01 MPBS + 50 mg/kg CORT injection; Sa + LBP + 50C, 
saline infusion + 1 mg/kg LBP + 50 mg/kg CORT injection; 
Ara-c + LBP + 50C, Ara-c infusion + 1 mg/kg LBP + 40 mg/kg 
CORT injection. Sa, normal saline in the osmotic bump; PBS, 
phosphates buffer; CORT, corticosterone; Ara-c, cytosine-b-d-
arabinofuranoside; LBP, Lycium barbarum.
Figure 8. Immobile time in FST in different groups after Ara-c 
infusion. *p < 0.05 compared to the Sa + PBS group; #p < 0.05 
compared to Sa + PBS + 40C group; $p < 0.05 compared to 
Sa + PBS + 50C group. Sa, normal saline in the osmotic bump; 
PBS, phosphates buffer; LBP, Lycium barbarum; 40C, 40 mg/kg 
corticosterone; 50C, 50 mg/kg corticosterone; Ara-c, cytosine-
b-d-arabinofuranoside; FST, forced swimming test.
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the antidepressant action of LBP. It has been found 
that classic antidepressant drugs such as fluoxetine 
exhibit antidepression via neurogenesis-dependent and 
neurogenesis- independent manner (11). Their recent 
work in a mice model of anxiety/depression has shown 
that efficacy of fluoxetine disappeared in novelty sup-
pressed feeding test after X-ray irradiation, whereas its effi-
cacy was kept intact in other depression behavior tests 
including FST and open field test after X-ray irradia-
tion. Another elegant work done by Bessa and his col-
leagues (3) shows that classic antidepressant drugs such 
as fluoxetine and imipramine restored the complexity of 
dendrite trees of neurons in the PFC and hippocampus 
after chronic mild stress. Intriguingly, the antidepres-
sive effects of these classic drugs were not abolished 
even when the hippocampal neurogenesis was ablated by 
methylazoxymethanol, a cytostatic agent. Therefore, our 
data showing that the efficacy of LBP is not affected by 
the ablation of adult neurogenesis strongly suggests that 
other neurogenesis- independent factors may play a more 
important role than neurogenesis in mediating the anti-
depressant action of LBP. Second, Ara-c is a widely used 
chemotherapeutic drug that is able to cause cell cycle arrest 
by inhibiting DNA synthesis. Hippocampal neurogene-
sis is a dynamic process that took place throughout the 
whole lifetime. Generally, adult neurogenesis in the hip-
pocampus undergoes five developmental stages: stage 1 
(Proliferation), stem cells located in the subgranular 
zone give rise to the transient amplifying cells; stage 2 
(Differentiation), the transient amplifying cells differ-
entiated into immature neurons; stage 3 (Migration), the 
immature neurons gradually migrated into the granular 
cell layer and then extend their axons to target on the neu-
rons in CA3 field (stage 4, Axonal targeting), and finally 
formed synaptic connections (stage 5, Synaptic integra-
tion). This whole process usually takes about 4 weeks to 
be completed (23). Thus, based on the pharmacological 
feature of Ara-c, the infusion of this drug is able to affect 
the proliferative stage (stage 1) alone and leave the rest 
of stages intact. In other words, newly born neurons ear-
lier than the implantation of the osmotic pump containing 
Ara-c are nearly intact. A previous study has proved that 
only long-term administration with fluoxetine enhances 
the maturation and the synaptic formation of adult-
borne hippocampal granular cells and hence improves 
the behavior outcomes (34). The findings indicate that 
the efficacy of classic antidepressant drugs rely on the 
maturation and integration of the newly born granular 
cells. Since Ara-c infusion in the present study only 
blocked the proliferation stage of the newly born gran-
ular cells, it is possible that the antidepressant effects 
of LBP did not require the new neurons proliferated 
from the stem cell pool. Alternatively, whether the anti-
depressant effect of LBP is mediated by the maturation 
and integration of the newly born granular cells needed 
to be further explored.
The Antidepressive Effect of LBP Is Associated  
With Enhanced Dendritic Plasticity and  
Increased Expression of PSD-95
Another feature of the hippocampus in depressed ani-
mals is retraction of apical dendrites of pyramidal cells in 
the CA3 region (26,36). Furthermore, the spine density of 
pyramidal cells in the CA3 region decreased after exposure 
to stressful events (31). Bessa and his colleagues (3) found 
that classic antidepressant drugs such as fluoxetine and 
imipramine restored the complexity of dendrite trees of 
neurons in the prefrontal cortex and hippocampus after 
chronic mild stress. Intriguingly, the antidepressive effects 
of these classic drugs were not abolished even when the 
hippocampal neurogenesis was ablated by MAM, a cyto-
static agent. These data indicate that the restoration of den-
dritic morphology is more important than the recovery of 
hippocampal neurogenesis in mediating the efficacy of the 
classic antidepressants. Therefore, we studied the dendritic 
morphology of CA3 pyramidal cells by Golgi staining and 
also the changes in expression level of two major synaptic 
proteins: synaptophysin and PSD-95. Our results showed 
that the major changes caused by 40 mg/kg CORT and 50 
mg/kg CORT injection was the robust decrease of spine 
density in apical dendrites. These findings echoed oth-
ers’ data (4,22,36). LBP not only reversed the slight atro-
phy of pyramidal cell bodies caused by 50 mg/kg CORT 
injection but also restored the number of spines in those 
cells after 40 and 50 mg/kg CORT challenges. These data 
further confirmed the protective effects of LBP on main-
taining the original morphology of mature neurons (39). 
More importantly, our results provide the first evidence by 
showing that LBP has the potential to specifically protect 
synaptic structures. LBP strongly increases the expression 
level of PSD-95 after 14-day injection of 40 and 50 mg/kg 
CORT. PSD-95 is abundantly distributed in the postsyn-
aptic part of synapse and plays a key role in maintaining 
synapses. Overexpression of PSD-95 increases spinogen-
esis and enhances the synaptic connection with presynaptic 
terminals (25). Furthermore, targeting the interaction mol-
ecules of PSD-95 also directly change the spine density in 
pyramidal cells. For instance, overexpression of diacylg-
lycerol kinase zeta (DAKzeta), which is known to interact 
with PSD-95 increases spine density in cultured neurons. 
Conversely, DGKzeta knockdown reduces spine density 
(19). Similar results are found in targeting another inter-
acting protein of PSD-95, TANC1 (15). Overexpression 
of TANC1 increases the spine density in cultured neurons. 
However, TANC1-deficient mice showed reduced spine 
density in the CA3 region and impaired spatial memory. 
All these evidence indicate that PSD-95 is a key player in 
maintaining spine density and spinogenesis. It is possible 
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that LBP restores the spine density through upregulating 
the expression of PSD-95.
CONCLUSION
Depression is a complicated clinical disease lacking 
efficient therapies. The present study shows that LBP 
exhibits an antidepressive potential in a rat model of 
depression. The antidepressant action of LBP may be 
more potent than the routine exercise intervention. By 
ablating adult neurogenesis, it indicates that LBP may 
play its role through a neurogenesis-independent way. 
Furthermore, the upregulation of the synaptic protein 
(PSD-95) and the restoration of apical spine density after 
LBP treatment indicated that the dendritic morphology in 
the CA3 region may be an important part for supporting 
the antidepressant effect of LBP. Whether other neuro-
genesis-independent factors are involved in the antide-
pressant action of LBP needs to be further explored.
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